Background: Medication abortion is a common method of pregnancy termination in the United States, however, the best way to manage pain during medication abortion is unknown. Most providers offer a combination of over the counter pain medications (most commonly ibuprofen) and narcotics. However, because narcotic pain medications can lead to addiction, better pain medications are ...Read more >
Antoinette Nguyen, MD, MPH, The University of North Carolina at Chapel Hill
Immediate post-abortion contraception is safe, acceptable to patients, and effective at reducing unintended pregnancy and subsequent abortion. However, many people face financial barriers that limit their ability to obtain effective contraception at the same clinic visit as an abortion. Out-of-pocket costs for abortion care and contraception can be substantial for many people, especially among those ...Read more >
Zoey Thill, MD, MPP, Albert Einstein College of Medicine
After abortion care, women typically receive information from providers and staff about what to expect after the abortion. This written or verbal information often includes instructions regarding if and how to take antibiotics, suggested strategies for managing pain and/or bleeding, a list of symptoms that should trigger return to care, and a list of behaviors ...Read more >
Sanithia Williams, MD, University of California, San Francisco
This is a qualitative study aiming to understanding Black women’s attitudes about and experiences with abortion, and how these attitudes are filtered through their racial identity. We propose a cross-sectional study of about 40 subjects from Northern California and the St Louis, Missouri metropolitan area. Participants will be asked to undergo semi-structured interviews approximately 60-90 ...Read more >
Lauren Thaxton, MD, MBA, University of New Mexico Health Sciences Center
In 2017, New Mexico expanded pharmacist prescribing privileges to include hormonal contraception. In this largely rural state, we sought to explore rural pharmacists and women’s opinions on this expansion of privileges including how it might affect access to contraception in local communities. We recruited pharmacists and women working and living in rural areas of New ...Read more >
Lauren Naliboff, DO, New York University School of Medicine
This will be a prospective, observational cohort study. The objective of this study is to evaluate for feasibility and acceptability the use of a pictorial menstrual chart via text messaging in a diverse, low income, low education, low literacy US population. Any patient who presents for insertion of an ENG implant or LNG-IUS will be ...Read more >
Jessica Tarleton, MD, MPH, University of Pittsburgh
Daily oral dosing of the antiretroviral drugs tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) has been approved by the FDA pre-exposure prophylaxis (PrEP). Oral PrEP has been shown to be highly effective in preventing HIV transmission through the rectum, but less effective, and in some studies ineffective, in preventing vaginal transmission. Determinants of tissue penetration of antiretroviral drugs are not ...Read more >
Background: Despite barriers to abortion provision, some physicians have successfully incorporated abortion care into their practices. Research identifying facilitators of abortion integration is limited. Characterizing factors associated with successful integration may inform interventions to increase abortion provision at the individual provider level. Objectives: To identify OB/GYN and Family Medicine physicians who have successfully integrated abortion ...Read more >
Glenmarie Matthews, MD, MBA, Albert Einstein College of Medicine
Abortion is restricted in Jamaica under the Offences Against the Person Act of 1864, which is based on the 1861 English Act of the same title. Abortion is legal only for the preservation of maternal mental and or physical health. Jamaican health care workers have advocated for changes to the law. A survey conducted in ...Read more >
We propose a randomized controlled double-blinded trial comparing gabapentin 600 mg to placebo as an adjunct to moderate sedation among patients undergoing outpatient same-day dilation and evacuation. The primary study outcome is pain during dilation and evacuation as recorded by 100-mm VAS. Secondary outcomes include need for additional doses of IV sedation, perioperative pain, anxiety, ...Read more >
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy